98%
921
2 minutes
20
Objective: This study explores radiomics and deep learning for predicting pulmonary metastasis in head and neck Adenoid Cystic Carcinoma (ACC), assessing machine learning(ML) algorithms' model performance.
Methods: The study retrospectively analyzed contrast-enhanced CT imaging data and clinical records from 130 patients with pathologically confirmed ACC in the head and neck region. The dataset was randomly split into training and test sets at a 7:3 ratio. Radiomic features and deep learning-derived features were extracted and subsequently integrated through multi-feature fusion. Z-score normalization was applied to training and test sets. Hypothesis testing selected significant features, followed by LASSO regression (5-fold CV) identifying 7 predictive features. Nine machine learning algorithms were employed to build predictive models for ACC pulmonary metastasis: ada, KNN, rf, NB, GLM, LDA, rpart, SVM-RBF, and GBM. Models were trained using the training set and tested on the test set. Model performance was evaluated using metrics such as recall, sensitivity, PPV, F1-score, precision, prevalence, NPV, specificity, accuracy, detection rate, detection prevalence, and balanced accuracy.
Results: Machine learning models based on multi-feature fusion of enhanced CT, utilizing KNN, SVM, rpart, GBM, NB, GLM, and LDA, demonstrated AUC values in the test set of 0.687, 0.863, 0.737, 0.793, 0.763, 0.867, and 0.844, respectively. Rf and ada showed significant overfitting. Among these, GBM and GLM showed higher stability in predicting pulmonary metastasis of head and neck ACC.
Conclusion: Radiomics and deep learning methods based on enhanced CT imaging can provide effective auxiliary tools for predicting pulmonary metastasis in head and neck ACC patients, showing promising potential for clinical application.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ejrad.2025.112377 | DOI Listing |
J Bras Pneumol
September 2025
. Departamento de Pneumologia, Centro Hospitalar Universitário de São João, Porto, Portugal.
Objectives: The 9th edition of the Tumor, Node, Metastasis (TNM-9) lung cancer classification is set to replace the 8th edition (TNM-8) starting in 2025. Key updates include the splitting of the mediastinal nodal category N2 into single- and multiple-station involvement, as well as the classification of multiple extrathoracic metastatic lesions as involving a single organ system (M1c1) or multiple organ systems (M1c2). This study aimed to assess how the TNM-9 revisions affect the final staging of lung cancer patients and how these changes correlate with overall survival (OS).
View Article and Find Full Text PDFMelanoma Res
September 2025
Gynecological Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS-CRO, National Cancer Institute Aviano, Aviano.
Peritoneal carcinomatosis represents an exceptionally rare metastatic pattern of cutaneous malignant melanoma, occurring in fewer than 1% of cases with distant spread and typically within the first few years after primary treatment. This report presents an unusual case with a markedly prolonged disease-free interval, clinically mimicking advanced ovarian carcinoma. We report the case of a 53-year-old woman treated more than 10 years ago for stage IIB nodular melanoma with surgery and adjuvant therapy.
View Article and Find Full Text PDFCancer Biother Radiopharm
September 2025
School of Food Science, Nanjing Xiaozhuang University, Nanjing, China.
Lung cancer remains one of the leading causes of cancer-related mortality worldwide, highlighting the urgent need for more effective and targeted therapeutic strategies. Traditional Chinese Medicine (TCM), known for its favorable safety profile and broad pharmacological effects, offers promising candidates for cancer treatment. Salvianolic acid F (SAF), a key bioactive compound derived from , has demonstrated antitumor potential, but its role and underlying mechanisms in lung cancer remain inadequately characterized.
View Article and Find Full Text PDFAnticancer Drugs
September 2025
Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College.
Nonsmall cell lung cancer (NSCLC) with SMARCA4 deficiency represents a rare subset of lung tumors characterized by early metastasis, poor response to chemotherapy, and unfavorable prognosis. Established therapy strategies for SMARCA4-deficient NSCLC remain elusive. While immune checkpoint inhibitors have been proposed as a potential solution, their efficacy remains uncertain.
View Article and Find Full Text PDFAnn Acad Med Singap
August 2025
Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
Introduction: Trastuzumab deruxtecan (T-DXd) has revolutionised treatment for metastatic breast cancer (MBC). While effective, its high cost and toxicities, such as fatigue and nausea, pose challenges.
Method: Medical records from the Joint Breast Cancer Registry in Singapore were used to study MBC patients treated with T-DXd (February 2021-June 2024).